Calcitonin Gene-Related Peptide Targeting Therapies for Migraine: A New Era for Migraine Treatment
Hong-Kyun Park, Byung-Kun Kim
J Korean Neurol Assoc. 2020;38(2):88-99. Published online 2020 May 1 DOI: https://doi.org/10.17340/jkna.2020.2.2
Citations to this article as recorded by 
One-step ultra-rapid immunoassay of calcitonin gene-related peptide for migraine diagnosis
Jeong Soo Sung, Jaeyong Jung, Soonil Kwon, Hyung Eun Bae, Min-Jung Kang, Joachim Jose, Misu Lee, Soomi Cho, Min Kyung Chu, Jae-Chul Pyun
Biosensors and Bioelectronics.2025; 270: 116980. CrossRef
One-Year Compliance After Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy for Migraine Patients in a Real-World Setting: A Multicenter Cross-Sectional Study
Mi-kyoung Kang, Jong-Hee Sohn, Myoung-Jin Cha, Yoo Hwan Kim, Yooha Hong, Hee-Jin Im, Soo-Jin Cho
Journal of Clinical Medicine.2025; 14(3): 734. CrossRef
Calcitonin Gene-Related Peptide Monoclonal Antibody Treatment in Nine Cases of Persistent Headache Following COVID-19-Infection
Soyoun Choi, Yooha Hong, Mi-Kyoung Kang, Tae-Jin Song, Soo-Jin Cho
Journal of Korean Medical Science.2025;[Epub] CrossRef
Prevention with 240 mg Galcanezumab of Episodic Cluster Headache
Heejung Mo, Min Jun Song, Soo-Jin Cho
Journal of the Korean Neurological Association.2021; 39(3): 228. CrossRef
Pharmacotherapy of migraine prevention based on the assessment of headache
Hee-Ji Im, Soo-Jin Cho
Journal of the Korean Medical Association.2020; 63(10): 644. CrossRef